Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 90Breast Neoplasms 21Insulin Resistance 18Obesity 14Prostatic Neoplasms 10Pancreatic Neoplasms 8Endometrial Neoplasms 7Infertility 6Anovulation 6Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 5Rectal Neoplasms 4Hyperandrogenism 4Weight Loss 3Squamous Cell Carcinoma of Head and Neck 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hyperinsulinism 3Head and Neck Neoplasms 3Diabetes Mellitus 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Recurrence 2Rare Diseases 2Premature Birth 2Overweight 2Ovarian Neoplasms 2Multiple Myeloma 2

Interventions

Fluorouracil 2Docetaxel 2thymoglobulin 1temsirolimus 1sargramostim 1pirarubicin 1pembrolizumab 1pazopanib 1fludarabine phosphate 1fludarabine 1cc-486 1X-Rays 1Whole-Body Irradiation 1Trastuzumab 1Tacrolimus 1Surveys and Questionnaires 1Rituximab 1Radiotherapy 1Proctectomy 1Pemetrexed 1Oxaliplatin 1Mycophenolic Acid 1Monatide (IMS 3015) 1Metformin 1Melphalan 1Leucovorin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Drug Therapy 1Diphenhydramine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pathologic Complete Response × Metformin × Clear all
NCT06728982 2025-08-01

Impact Of Metformin In Rectal Cancer Patients

Minia University

Phase 2/3 Completed
85 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡